TriSalus Life Sciences Ownership | Who Owns TriSalus Life Sciences?
TriSalus Life Sciences Ownership Summary
TriSalus Life Sciences is owned by 22.22% institutional investors, 42.41% insiders, and 35.37% retail investors. Nantahala capital management is the largest institutional shareholder, holding 4.81% of TLSI shares.
TLSI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | TriSalus Life Sciences | 22.22% | 42.41% | 35.37% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Medical Device Stocks | 37.83% | 10.48% | 51.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nantahala capital management | 2.07M | 4.81% | $14.45M |
| Blackrock funding, inc. /de | 1.53M | 3.56% | $10.71M |
| Vanguard group | 1.53M | 3.56% | $10.68M |
| Gilder gagnon howe | 1.05M | 3.18% | $4.87M |
| Wasatch advisors lp | 1.44M | 3.07% | $5.75M |
| Awm investment company | 1.24M | 2.89% | $8.68M |
| Geode capital management | 751.21K | 1.74% | $5.25M |
| Alyeska investment group | 557.50K | 1.69% | $2.59M |
| Morgan stanley | 365.25K | 0.85% | $2.55M |
| State street | 192.63K | 0.59% | $895.74K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Perkins capital management | 230.10K | 0.86% | $920.40K |
| Awm investment company | 1.24M | 0.84% | $8.68M |
| Nantahala capital management | 2.07M | 0.48% | $14.45M |
| Connective capital management | 32.80K | 0.14% | $152.50K |
| Msd partners | 40.00K | 0.12% | $186.00K |
| White pine capital | 58.55K | 0.11% | $408.69K |
| Empire financial management company | 72.03K | 0.11% | $502.75K |
| Gilder gagnon howe | 1.05M | 0.05% | $4.87M |
| Wasatch advisors lp | 1.44M | 0.04% | $5.75M |
| Highmark wealth management | 10.80K | 0.03% | $75.38K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wasatch advisors lp | 1.44M | 0.04% | 1.44M |
| Blackrock funding, inc. /de | 1.53M | 0.00% | 746.47K |
| Vanguard group | 1.53M | 0.00% | 371.13K |
| Morgan stanley | 365.25K | 0.00% | 347.28K |
| Perkins capital management | 230.10K | 0.86% | 230.10K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wealthcare advisory partners | - | - | -643.74K |
| Duquesne family office | - | - | -426.92K |
| Goldman sachs group | 65.97K | 0.00% | -84.52K |
| Gilder gagnon howe | 1.05M | 0.05% | -45.92K |
| Vestcor | - | - | -23.38K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Wasatch advisors lp | 1.44M | 0.04% | 1.44M | $5.75M |
| Perkins capital management | 230.10K | 0.86% | 230.10K | $920.40K |
| Ci private wealth | 75.70K | 0.00% | 75.70K | $352.00K |
| Squarepoint ops | 73.71K | 0.00% | 73.71K | $342.73K |
| Empire financial management company | 72.03K | 0.11% | 72.03K | $502.75K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Sbi securities | -2.00 |
| Advisor group | -79.00 |
| Coldstream capital management | -150.00 |
| Wolverine asset management | -820.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 44 | -18.52% | 9,567,686 | 0.05% | 22 | 2.63% | 27 | -3.57% | 10 | -9.09% |
| Sep 30, 2025 | 51 | 8.51% | 8,972,933 | 5.93% | 27 | 4.11% | 27 | -28.95% | 11 | 450.00% |
| Jun 30, 2025 | 47 | 42.42% | 8,470,337 | 187.35% | 25 | 24.11% | 38 | 72.73% | 2 | 100.00% |
| Mar 31, 2025 | 1 | -96.15% | 4,008 | -99.83% | - | 0.02% | 1 | -85.71% | - | -100.00% |
| Dec 31, 2024 | 25 | -19.35% | 2,295,289 | 5.72% | 8 | 12.90% | 7 | -50.00% | 8 | -11.11% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 16, 2026 | Devlin Jodi | Chief of Clinical Operations | Sell | $1.12K |
| Mar 12, 2026 | Devlin Jodi | Chief of Clinical Operations | Sell | $7.25K |
| Mar 11, 2026 | Devlin Jodi | Chief of Clinical Operations | Sell | $4.80K |
| Mar 11, 2026 | Cox Bryan F. | Chief of Research | Sell | $4.70K |
| Mar 12, 2026 | Cox Bryan F. | Chief of Research | Sell | $6.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 6 | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 4 |
| 2025 Q1 | 8 | - |
TLSI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools